E-xtra Design MultiBranch Stent Graft System
Thoracoabdominal Aortic Aneurysms (TAAA)
CommercialApproved
Key Facts
About Artivion
Artivion is a global medical device company dedicated to advancing the treatment of aortic diseases through a focused portfolio of surgical and endovascular solutions. The company's strategic acquisitions, including Ascyrus Medical and the On-X heart valve technology, have positioned it as a leader in aortic arch repair and mechanical heart valves. With over 1,600 employees worldwide, Artivion is driving patient-powered progress by collaborating with surgeons to address their most difficult challenges, supported by a robust clinical pipeline and recent regulatory milestones like the FDA HDE for its AMDS device.
View full company profileTherapeutic Areas
Other Thoracoabdominal Aortic Aneurysms (TAAA) Drugs
| Drug | Company | Phase |
|---|---|---|
| E-nside TAAA Multibranch Stent Graft System | Artivion | Commercial |